Respiratory and cardiometabolic comorbidities and stage I-III non-small cell lung cancer (NSCLC) survival: A pooled analysis from the International Lung Cancer Consortium (ILCCO)
Publication date:
2022
Publisher version:
Description:
European Society for Medical Oncology, ESMO Congress (2022. Paris, France)